Lab Notes: Adaptimmune to expand manufacturing at Navy Yard; Helius raises $18M with stock sale
August 12, 2022 at 11:42 AM EDT
A Philadelphia biotechnology company gets orphan drug status for its new drug candidate.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |